Clinical Trial Update: Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with adenine phosphoribosyltra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenine Phosphoribosyltransferase Deficiency

Drugs mentioned

• Allopurinol (Allopurinol)
• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Landspitali University Hospital | Conditions: Adenine Phosphoribosyltransferase Deficiency | Phase 4 | Status: COMPLETED | Results posted: 2017-12-27